checkAd

     152  0 Kommentare Ascendis Pharma A/S Announces Participation in ENDO Online 2020 - Seite 3

    Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group. June 2020 Ascendis Pharma A/S. 

    CONTACT: Investor contact: 
Patti Bank 
Westwicke Partners
(415) 513-1284
patti.bank@westwicke.com
       
Media contact:
Ami Knoefler
Ascendis Pharma
(650) 739-9952  
ack@ascendispharma.com 
ir@ascendispharma.com

    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Ascendis Pharma A/S Announces Participation in ENDO Online 2020 - Seite 3 COPENHAGEN, Denmark, June 08, 2020 (GLOBE NEWSWIRE) - Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced presentations related to its …